Q3 2025 Holdings
Filed 2025-11-14 | 38 holdings | $540.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $43.8M | 57,376 | 8.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $35.9M | 154,834 | 6.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $32.3M | 622,729 | 6.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $31.9M | 71,343 | 5.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $28.8M | 144,954 | 5.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $28.3M | 418,245 | 5.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $26.3M | 667,615 | 4.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.7M | 262,972 | 4.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $24.8M | 1,614,717 | 4.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $24.8M | 451,581 | 4.6% |
| Natera Inc(NTRA) | COM | 632307104 | $23.9M | 148,369 | 4.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $19.9M | 35,344 | 3.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $18.3M | 651,810 | 3.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $16.5M | 282,940 | 3.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $14.3M | 216,527 | 2.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $13.8M | 162,141 | 2.5% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $13.7M | 287,090 | 2.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $13.6M | 248,987 | 2.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $13.3M | 1,128,521 | 2.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $13.2M | 884,890 | 2.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.5M | 263,256 | 2.1% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.0M | 684,508 | 1.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $8.8M | 291,262 | 1.6% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $8.3M | 5,214,236 | 1.5% |
| Grail Inc(GRAL) | COM | 384747101 | $8.2M | 137,928 | 1.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.5M | 1,500,793 | 1.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $5.5M | 294,360 | 1.0% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $5.1M | 53,333 | 0.9% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $3.5M | 586,909 | 0.7% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $2.7M | 1,061,132 | 0.5% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $1.7M | 118,279 | 0.3% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $1.3M | 528,993 | 0.2% |
| Atai Life Sciences NV | SHS | N0731H103 | $1.0M | 196,858 | 0.2% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $992.6K | 684,541 | 0.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $954.5K | 133,131 | 0.2% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $935.1K | 142,984 | 0.2% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $752.9K | 12,010 | 0.1% |
| Sensei Biotherapeutics Inc(SNSE) | COM NEW | 81728A207 | $139.1K | 14,718 | 0.0% |